Drug-Food Interaction Study of Seville Orange Juice and Colchicine

Completed · Phase 1

Conditions studied: Healthy

In brief

Seville orange juice is an inhibitor of the intestinal cytochrome P450 (CYP) 3A4 enzyme, one of the enzymes responsible for the metabolism of colchicine. This study will evaluate the effect of multiple daily consumptions of Seville orange juice on the pharmacokinetic profile of a single 0.6 mg dose of colchicine. A secondary objective is to evaluate the safety and tolerability of this regimen in healthy volunteers. All study subjects will be monitored for adverse events throughout the study period.

Key facts

Study ID
NCT00960193
Run by
Mutual Pharmaceutical Company, Inc.
People needed
24
Starts
2009-02-01
Expected to finish
2009-04-01
Last updated by the study team
2011-06-08

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.